IZOLIROVANNAYa SISTOLIChESKAYa ARTERIAL'NAYa GIPERTENZIYa: GLOBAL'NYY FAKTOR RISKA


Citar

Texto integral

Resumo

Significance of isolated systolic hypertension as a cardiovascular and renal risk factor is discussed.

Sobre autores

- -

Bibliografia

  1. Комитет экспертов РМОАГ / ВНОК. Диагностика и лечение артериальной гипертензии. Рекомендации РМОАГ/ВНОК. Системные гипертензии 2010; 3: 5 - 26
  2. Nawrot T., Den Hond E., Thijs L., Staessen J.A. Isolated systolic hypertension and the risk of vascular disease. Curr. Hypertens. Rep. 2003; 5: 372 - 379
  3. London G., Marchais S., Guérin A., Métivier F. Arterial hypertension, chronic renal insufficiency and dialysis. Nephrol. Ther. 2007; 3 Suppl 3: S156-S161
  4. Ochodnicky P., Henning R.H., van Dokkum R.P., de Zeeuw D. Microalbuminuria and endothelial dysfunction: emerging targets for primary prevention of end-organ damage. Cardiovasc. Pharmacol. 2006; 47 (Suppl. 2): S151 - S162
  5. Tsakiris A., Doumas M., Lagatouras D. et al. Microalbuminuria is determined by systolic and pulse pressure over a 12-year period and related to peripheral artery disease in normotensive and hypertensive subjects: the Three Areas Study in Greece (TAS-GR). Angiology. 2006; 57 (3): 313 - 320
  6. Gerber L.M., Shmukler C., Alderman M.H. Differences in urinary albumin excretion rate between normotensive and hypertensive, white and nonwhite subjects. Arch. Intern. Med. 1992; 152: 373 - 377
  7. Hanada S., Ando R., Naito S. et al. Assessment and significance of abdominal aortic calcification in chronic kidney disease. Nephrol. Dial. Transplant. 2010; 25(6): 1888-1895
  8. Okuno S., Ishimura E., Kitatani K. et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am. J. Kidney Dis. 2007; 49(3): 417-425
  9. McEniery C.M., McDonnell B.J., So A. et al.; Anglo-Cardiff Collaboration Trial Investigators. Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertension. 2009; 53(3): 524-531
  10. Cheng L.T., Gao Y.L., Gu Y. et al. Stepwise increase in the prevalence of isolated systolic hypertension with the stages of chronic kidney disease. Nephrol. Dial. Transplant. 2008; 23(12): 3895-3900
  11. Howes L., Reld L., Bendle R., Weaving J. The prevalence of isolated systolic hypertension in patients of 60 years and over attending Australian general practitioners. Blood Press. 1998; 7: 139 - 143
  12. Antikainen R.L., Jousilahti P., Tuomilehto J. Trends in the prevalence of isolated systolic hypertension in the middle-aged population in 1972-1992. J. Hum. Hypertens. 1999;13: 485 - 491
  13. Yeh C.J., Pan W.H., Jong Y.S. et al. Incidence and predictors of isolated systolic hypertension and isolated diastolic hypertension in Taiwan. J. Formos. Med. Assoc. 2001; 100: 668 - 675
  14. Martins D., Nelson K., Pan D. The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III. J. Gend. Specif. Med. 2001; 4: 10 - 13
  15. Franklin S.S., Jacobs M.J., Wong N.D. et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001; 37: 869 - 874
  16. Hyman D.J., Pavlik V.N. Characteristics of patients with uncontrolled hypertension in the United States. N. Engl. J. Med. 2001; 345: 479 - 486
  17. Whyte J.L., Lapuerta P., L'Italien G.J., Franklin S.S. The challenge of controlling systolic blood pressure: data from the National Health and Nutrition Examination Survey (NHANES III), 1988-1994. J. Clin. Hypertens. (Greenwich). 2001; 3: 211 - 216
  18. O'Rourke M.F. Isolated systolic hypertension, pulse pressure, and arterial stiffness as risk factors for cardiovascular disease. Curr. Hypertens. Rep. 1999; 1: 204 - 211
  19. Beltran A., McVeigh G., Morgan D. et al. Arterial compliance abnormalities in isolated systolic hypertension. Am. J. Hypertens. 2001; 14:1007 - 1011
  20. Lip G.Y., Blann A.D., Beevers D.G. Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension. J. Hypertens. 1999; 17: 1203 - 1207
  21. Cirillo M., Stellato D., Laurenzi M. et al Pulse pressure and isolated systolic hypertension: association with microalbuminuria. The GUBBIO Study Collaborative Research Group. Kidney Int. 2000; 58: 1211 - 8
  22. Bog-Hansen E., Lindblad U., Ranstam J. et al. Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project. Diabetes. Obes. Metab. 2001; 3: 25 - 31
  23. Denolle T., Gallois H., L'Hostis P., Cimarosti I. Characteristics of patients with isolated systolic hypertension in relation to body mass index. The PREHSI study. Arch. Mal. Coeur. Vaiss. 2002; 95: 683 - 636
  24. Kannel W.B. Elevated systolic blood pressure as a cardiovascular risk factor. Am. J. Cardiol. 2000; 85: 251 - 255
  25. Stampler J., Stampler R., Neaton J. Blood pressure, systolic and diastolic, and cardiovascular risks. Arch. Intern. Med. 1993; 153: 598 - 615
  26. Broda G. Isolated systolic hypertension is a strong predictor of cardiovascular and all-cause mortality in the middle-aged population: Warsaw Pol-MONICA Follow up Project. J. Clin. Hypertens. (Greenwich). 2000; 2: 305 - 311
  27. Qureshi A.I., Suri M.F., Mohammad Y. et al. Isolated and borderline isolated systolic hypertension relative to long-term risk and type of stroke: a 20-year follow-up of the national health and nutrition survey. Stroke 2002; 33: 2781 - 2788
  28. Pini R., Cavallini M.C., Bencini F. et al. Cardiovascular remodeling is greater in isolated systolic hypertension than in diastolic hypertension in older adults: the Insufficienza Cardiaca negli Anziani Residenti (ICARE) a Dicomano Study. J. Am. Coll. Cardiol. 2002; 40:1283 - 1289
  29. Hozawa A., Ohkubo T., Nagai K. et al. Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: the Ohasama study. Arch. Intern. Med. 2000; 160:3301 - 3306
  30. Cicconetti P., Morelli S., Ottaviani L. et al. Blunted nocturnal fall in blood pressure and left ventricular mass in elderly individuals with recently diagnosed isolated systolic hypertension. Am. J. Hypertens. 2003; 16 (11 Pt. 1): 900 - 905
  31. Aronson S., Boisvert D., Lapp W. Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery. Anesth. Analg. 2002; 94:1079 - 1084
  32. Vikse B.E., Aasarod K., Bostad L., Iversen B.M. Clinical prognostic factors in biopsy-proven benign nephrosclerosis. Nephrol. Dial. Transplant. 2003; 18: 517 - 523
  33. Castellani S., Ungar A., Cantini C. et al. Impaired renal adaptation to stress in the elderly with isolated systolic hypertension. Hypertension 1999; 34: 1106 - 1111
  34. Mentari E., Rahman M. Blood pressure and progression of chronic kidney disease: importance of systolic, diastolic, or diurnal variation. Curr. Hypertens. Rep. 2004; 6(5): 400-404
  35. Agarwal R., Andersen M.J. Correlates of systolic hypertension in patients with chronic kidney disease. Hypertension. 2005; 46(3): 514-520
  36. Kendrick J., Chonchol M., Gnahn H., Sander D. Higher systolic blood pressure is associated with progression of carotid intima-media thickness in patients with chronic kidney disease. Kidney Int. 2010; 77(9): 794-800
  37. Alcasar J.M., Rodicio J.L. Ischemic nephropathy: clinical characteristics and treatment. Am. J. Kidney. Dis. 2000; 36: 883 - 893
  38. Фомин В.В. Ишемическая болезнь почек: клинико-патогенетические особенности, диагностика, лечение. Клин. мед. 2008; 4: 8 - 14
  39. Staessen J.A., Gasowski J., Wang J.G. et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355: 865 - 872
  40. Alam M.G., Barri Y.M. Systolic blood pressure is the main etiology for poorly controlled hypertension. Am. J. Hypertens. 2003; 16:140 - 143
  41. Borenstein J., Whyte J.L., Badamgarav E. et al. Physician practice patterns in the treatment of isolated systolic hypertension in a primary care setting. J. Clin. Hypertens. (Greenwich) 2002; 4: 93 - 100
  42. Moore T.J., Conlin P.R., Ard J., Svetkey L.P. DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension 2001; 38:155 - 158
  43. Staessen J.A., Fagard R., Thijs L. et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757 - 764
  44. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J. Hypertens. 2004; 22: 847 - 857.
  45. SHEP Cooperative Research Study Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. J.A.M.A. 1991; 265: 3255 - 3264
  46. Sutton-Tyrrell K., Wildman R., Newman A. et al. Extent of cardiovascular risk reduction associated with treatment of isolated systolic hypertension. Arch. Intern. Med. 2003; 163: 2728 - 2731
  47. Ramakrishna G., Schechter C.B., Phillips R. Diagnosis and treatment of isolated systolic hypertension in the elderly: results of a survey four years post-SHEP. Am. J. Geriatr. Cardiol. 1997; 6: 21 - 36
  48. Ferrucci L., Furberg C.D., Penninx B.W. et al. Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile. Circulation 2001; 104: 1923 - 1926
  49. Perry H.M. Jr., Davis B.R., Price T.R. et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). J.A.M.A. 2000; 284: 465 - 471
  50. Young J.H., Klag M.J., Muntner P. et al. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J. Am. Soc. Nephrol. 2002; 13: 2776 - 2782
  51. Zillich A.J., Garg J., Basu S. et al. Thiazide diuretics, potassium and the development of diabetes. A quantative review. Hypertension 2006; 48: 219 - 224
  52. Sowers J.R., Neutel J.M., Saunders E. et al. Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes. J. Clin. Hypertens. (Greenwich). 2006; 8(7): 470-480
  53. Chrysant S.G., Neutel J.M., Ferdinand K.C.; INCLUSIVE investigators. Irbesartan/hydrochlorothiazide for the treatment of isolated systolic hypertension: a subgroup analysis of the INCLUSIVE trial. J. Natl. Med. Assoc. 2009; 101(4): 300-307
  54. Kark M., Karnehed N., Rasmussen F. Blood pressure in young adulthood and later disability pension. A population-based study on 867 672 men from Sweden. Blood Press. 2007;16(6): 362-366

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies